Exodus Point Capital Management, LP Editas Medicine, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

A detailed history of Exodus Point Capital Management, LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 261,381 shares of EDIT stock, worth $752,777. This represents 0.01% of its overall portfolio holdings.

Number of Shares
261,381
Holding current value
$752,777
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$4.67 - $7.28 $1.22 Million - $1.9 Million
261,381 New
261,381 $1.22 Million
Q3 2023

Nov 09, 2023
SELL
$6.92 - $9.31 $1.96 Million - $2.64 Million
-283,301 Reduced 71.16%
114,790 $895,000
Q2 2023

Aug 10, 2023
BUY
$6.36 - $11.47 $2.38 Million - $4.28 Million
373,454 Added 1515.83%
398,091 $3.28 Million
Q1 2023

May 11, 2023
BUY
$7.03 - $11.53 $173,198 - $284,064
24,637 New
24,637 $179,000
Q3 2022

Nov 10, 2022
SELL
$12.16 - $19.42 $509,601 - $813,853
-41,908 Reduced 47.93%
45,521 $557,000
Q2 2022

Aug 19, 2022
BUY
$9.99 - $21.35 $873,415 - $1.87 Million
87,429 New
87,429 $1.03 Million
Q1 2022

May 13, 2022
SELL
$14.08 - $27.63 $723,275 - $1.42 Million
-51,369 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$26.55 - $40.57 $26,656 - $40,732
1,004 Added 1.99%
51,369 $1.36 Million
Q3 2021

Nov 15, 2021
BUY
$39.27 - $72.94 $1.98 Million - $3.67 Million
50,365 New
50,365 $2.07 Million
Q2 2021

Aug 16, 2021
SELL
$31.29 - $56.64 $206,733 - $374,220
-6,607 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$39.71 - $90.58 $96,535 - $220,199
2,431 Added 58.21%
6,607 $277,000
Q4 2020

Feb 16, 2021
SELL
$27.07 - $84.35 $1.16 Million - $3.61 Million
-42,843 Reduced 91.12%
4,176 $293,000
Q3 2020

Nov 16, 2020
BUY
$28.06 - $37.16 $605,057 - $801,281
21,563 Added 84.71%
47,019 $1.32 Million
Q2 2020

Aug 14, 2020
BUY
$18.5 - $34.34 $470,936 - $874,159
25,456 New
25,456 $753,000
Q1 2020

May 15, 2020
SELL
$14.88 - $32.78 $248,451 - $547,327
-16,697 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.49 - $32.63 $325,424 - $544,823
16,697 New
16,697 $494,000

Others Institutions Holding EDIT

# of Institutions
244
Shares Held
58.9M
Call Options Held
494K
Put Options Held
417K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $198M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email